Brief: Leading Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Revolution Medicines Stockholders Vote "FOR" Proposed Acquisition Of EQRx, Inc
01/11/2023 11:27
Nov 1 (Reuters) - EQRx Inc EQRX.O :
* LEADING INDEPENDENT PROXY ADVISORY FIRMS ISS AND GLASS
LEWIS
RECOMMEND REVOLUTION MEDICINES STOCKHOLDERS VOTE "FOR" PROPOSED
ACQUISITION OF EQRX, INC
Source text for Eikon: ID:nGNX3FNwK6
Further company coverage: EQRX.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on EQRx
See all newsBrief: Leading Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Revolution Medicines Stockholders Vote "FOR" Proposed Acquisition Of EQRx, Inc
Brief: Revolution Medicines Inc Says Will Acquire EQRx In An All-Stock Transaction
U.S. RESEARCH ROUNDUP- Cigna Group, McKesson, Zscaler
Brief: EQRx posts Q1 EPS USD -0.17
Brief: EQRx Says Jami Rubin Will Step Down As Chief Financial Officer